Site records / India / FEI 3005074449

Maneesh Pharmaceuticals LimitedMumbai

FDA-registered drug establishment in Mumbai: analysis, label, manufacture, pack. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.

Inspections posted: 1
Last inspection: Jul 2016 · VAI
Warning letters to this FEI: 0
Import alerts at this address: 0
US border refusals, 2 years: 1

The site dossier

This site, graded.
Every fact sourced.

A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
Warning-letter violations, numbered and labelled
Import-alert history rebuilt from the archive, each listing checked against this address
Border refusals by product, and the company's other sites, each graded
A hash of every source read, so the PDF can be checked against the record

On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.

PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.

By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.

Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan

Inspections

1 FDA inspection of this FEI, by end date; 1 with a posted classification.

13 Jul 2016VAI · Voluntary Action IndicatedFood Composition, Standards, Labeling and Econ · 0 citations posted

Warning letters and compliance actions

No FDA compliance action recorded against this FEI or letter to its name.

Import alerts in force

No listing in force under this firm's name.

Registration

FEI: 3005074449
DUNS: 918536145
Registered as: Maneesh Pharmaceuticals Limited
Registrant: Maneesh Pharmaceuticals Limited
Address: Plot No. 29-33, Ancillary Industrial Plots,Waman Patil Marg Deonar, Mumbai, MH 400043, India (IND)
Operations: ANALYSIS, LABEL, MANUFACTURE, PACK
Registration expires: 31 Dec 2026

Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.